The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

BACKGROUND: Percutaneous coronary intervention (PCI) is one of the most performed well-succeeded therapeutic procedures worldwide, reducing symptoms and improving quality of life. Neutrophil Gelatinase-associated Lipocalin (NGAL) is a biomarker of acute kidney injury (AKI) produced early after an is...

Descripción completa

Detalles Bibliográficos
Autores principales: Feitosa, Mateus Paiva Marques, Lima, Eduardo Gomes, Abizaid, Alexandre Antônio Cunha, Mehran, Roxana, Lopes, Neuza Helena Moreira, de Assis Fischer Ramos, Thiago, Hideo-Kajita, Alexandre, Filho, Roberto Kalil, Junior, Carlos Vicente Serrano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291785/
https://www.ncbi.nlm.nih.gov/pubmed/37365618
http://dx.doi.org/10.1186/s13098-023-01107-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291785/
https://www.ncbi.nlm.nih.gov/pubmed/37365618
http://dx.doi.org/10.1186/s13098-023-01107-9

Ejemplares similares